Ars Investment Partners, LLC Organon & Co. Transaction History

Ars Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	BUY	$23.4 - $34.25 $79,911 - $116,963	3,415 Added 4.12%	86,332 $2.02 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $13,641 - $17,633	-448 Reduced 0.54%	82,917 $2.9 Million
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $570,934 - $739,406	-19,914 Reduced 19.28%	83,365 $2.54 Million
Q3 2021 Nov 05, 2021	BUY	$28.63 - $35.64 $1.18 Million - $1.47 Million	41,295 Added 66.62%	103,279 $3.39 Million
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $1.76 Million - $2.36 Million	61,984 New	61,984 $1.88 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.02B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Investment Partners, LLC with notifications on news.